nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—CYP1A2—Betaxolol—glaucoma	0.0739	0.104	CbGbCtD
Apixaban—CYP2C19—Methazolamide—glaucoma	0.0607	0.0857	CbGbCtD
Apixaban—CYP2C9—Diclofenamide—glaucoma	0.0586	0.0828	CbGbCtD
Apixaban—CYP2C9—Dorzolamide—glaucoma	0.0566	0.0799	CbGbCtD
Apixaban—CYP3A5—Clonidine—glaucoma	0.0544	0.0768	CbGbCtD
Apixaban—CYP2C19—Timolol—glaucoma	0.0516	0.0729	CbGbCtD
Apixaban—CYP2C9—Methazolamide—glaucoma	0.0505	0.0712	CbGbCtD
Apixaban—CYP3A4—Pilocarpine—glaucoma	0.0434	0.0613	CbGbCtD
Apixaban—ABCB1—Timolol—glaucoma	0.0416	0.0588	CbGbCtD
Apixaban—CYP1A2—Clonidine—glaucoma	0.0405	0.0572	CbGbCtD
Apixaban—ABCB1—Clonidine—glaucoma	0.0354	0.05	CbGbCtD
Apixaban—CYP3A4—Brinzolamide—glaucoma	0.0341	0.0481	CbGbCtD
Apixaban—CYP3A4—Dorzolamide—glaucoma	0.0329	0.0465	CbGbCtD
Apixaban—CYP3A4—Methazolamide—glaucoma	0.0293	0.0414	CbGbCtD
Apixaban—CYP3A4—Acetazolamide—glaucoma	0.0235	0.0331	CbGbCtD
Apixaban—CYP3A4—Clonidine—glaucoma	0.0212	0.0299	CbGbCtD
Apixaban—Conjunctival haemorrhage—Bimatoprost—glaucoma	0.00658	0.0291	CcSEcCtD
Apixaban—Retinal haemorrhage—Bimatoprost—glaucoma	0.00658	0.0291	CcSEcCtD
Apixaban—Conjunctival haemorrhage—Brimonidine—glaucoma	0.00583	0.0258	CcSEcCtD
Apixaban—Retinal haemorrhage—Travoprost—glaucoma	0.00554	0.0245	CcSEcCtD
Apixaban—Conjunctival haemorrhage—Travoprost—glaucoma	0.00554	0.0245	CcSEcCtD
Apixaban—Drug hypersensitivity—Travoprost—glaucoma	0.00448	0.0198	CcSEcCtD
Apixaban—Haemorrhage intracranial—Pilocarpine—glaucoma	0.00418	0.0185	CcSEcCtD
Apixaban—Eye haemorrhage—Pilocarpine—glaucoma	0.00365	0.0162	CcSEcCtD
Apixaban—Melaena—Methazolamide—glaucoma	0.00279	0.0124	CcSEcCtD
Apixaban—Diabetes mellitus—Carteolol—glaucoma	0.00263	0.0117	CcSEcCtD
Apixaban—Eye haemorrhage—Betaxolol—glaucoma	0.00254	0.0112	CcSEcCtD
Apixaban—Metrorrhagia—Travoprost—glaucoma	0.00253	0.0112	CcSEcCtD
Apixaban—Diabetes mellitus—Levobunolol—glaucoma	0.00249	0.011	CcSEcCtD
Apixaban—Metrorrhagia—Pilocarpine—glaucoma	0.0024	0.0106	CcSEcCtD
Apixaban—Vaginal haemorrhage—Pilocarpine—glaucoma	0.00231	0.0102	CcSEcCtD
Apixaban—Menorrhagia—Pilocarpine—glaucoma	0.00231	0.0102	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Carbachol—glaucoma	0.0022	0.00974	CcSEcCtD
Apixaban—Melaena—Acetazolamide—glaucoma	0.00193	0.00856	CcSEcCtD
Apixaban—Epistaxis—Metipranolol—glaucoma	0.0018	0.00796	CcSEcCtD
Apixaban—Melaena—Pilocarpine—glaucoma	0.00167	0.00741	CcSEcCtD
Apixaban—Hypersensitivity—Dipivefrin—glaucoma	0.00159	0.00706	CcSEcCtD
Apixaban—Diabetes mellitus—Brimonidine—glaucoma	0.00158	0.00702	CcSEcCtD
Apixaban—Haematuria—Methazolamide—glaucoma	0.00152	0.00675	CcSEcCtD
Apixaban—Nausea—Physostigmine—glaucoma	0.00151	0.00669	CcSEcCtD
Apixaban—Liver function test abnormal—Bimatoprost—glaucoma	0.00144	0.00636	CcSEcCtD
Apixaban—Connective tissue disorder—Latanoprost—glaucoma	0.00137	0.00604	CcSEcCtD
Apixaban—Mediastinal disorder—Latanoprost—glaucoma	0.00125	0.00554	CcSEcCtD
Apixaban—Syncope—Carteolol—glaucoma	0.00124	0.00548	CcSEcCtD
Apixaban—Loss of consciousness—Carteolol—glaucoma	0.00121	0.00537	CcSEcCtD
Apixaban—Liver function test abnormal—Brinzolamide—glaucoma	0.00119	0.00529	CcSEcCtD
Apixaban—Syncope—Carbachol—glaucoma	0.00119	0.00526	CcSEcCtD
Apixaban—Syncope—Levobunolol—glaucoma	0.00117	0.00518	CcSEcCtD
Apixaban—Breast disorder—Brinzolamide—glaucoma	0.00117	0.00518	CcSEcCtD
Apixaban—Loss of consciousness—Carbachol—glaucoma	0.00116	0.00515	CcSEcCtD
Apixaban—Liver function test abnormal—Pilocarpine—glaucoma	0.00115	0.00508	CcSEcCtD
Apixaban—Loss of consciousness—Levobunolol—glaucoma	0.00115	0.00507	CcSEcCtD
Apixaban—Haemorrhage—Apraclonidine—glaucoma	0.00111	0.00492	CcSEcCtD
Apixaban—Shock—Carteolol—glaucoma	0.00111	0.00491	CcSEcCtD
Apixaban—Thrombocytopenia—Diclofenamide—glaucoma	0.00108	0.0048	CcSEcCtD
Apixaban—Shock—Carbachol—glaucoma	0.00106	0.00471	CcSEcCtD
Apixaban—Connective tissue disorder—Bimatoprost—glaucoma	0.00106	0.00468	CcSEcCtD
Apixaban—Haematuria—Acetazolamide—glaucoma	0.00106	0.00467	CcSEcCtD
Apixaban—Hypotension—Carteolol—glaucoma	0.00105	0.00466	CcSEcCtD
Apixaban—Shock—Levobunolol—glaucoma	0.00105	0.00464	CcSEcCtD
Apixaban—Hepatobiliary disease—Acetazolamide—glaucoma	0.00105	0.00463	CcSEcCtD
Apixaban—Eye disorder—Apraclonidine—glaucoma	0.00104	0.0046	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Latanoprost—glaucoma	0.00102	0.00453	CcSEcCtD
Apixaban—Anaphylactic shock—Methazolamide—glaucoma	0.00102	0.00451	CcSEcCtD
Apixaban—Hypotension—Carbachol—glaucoma	0.00101	0.00447	CcSEcCtD
Apixaban—Angiopathy—Apraclonidine—glaucoma	0.00101	0.00446	CcSEcCtD
Apixaban—Eye disorder—Bimatoprost—glaucoma	0.00101	0.00446	CcSEcCtD
Apixaban—Mediastinal disorder—Apraclonidine—glaucoma	0.001	0.00443	CcSEcCtD
Apixaban—Hypotension—Levobunolol—glaucoma	0.000994	0.0044	CcSEcCtD
Apixaban—Diabetes mellitus—Betaxolol—glaucoma	0.000994	0.0044	CcSEcCtD
Apixaban—Angiopathy—Bimatoprost—glaucoma	0.000977	0.00433	CcSEcCtD
Apixaban—Mediastinal disorder—Bimatoprost—glaucoma	0.00097	0.0043	CcSEcCtD
Apixaban—Nervous system disorder—Latanoprost—glaucoma	0.000968	0.00429	CcSEcCtD
Apixaban—Skin disorder—Latanoprost—glaucoma	0.000959	0.00424	CcSEcCtD
Apixaban—Epistaxis—Dorzolamide—glaucoma	0.000957	0.00424	CcSEcCtD
Apixaban—Gastrointestinal disorder—Diclofenamide—glaucoma	0.000956	0.00423	CcSEcCtD
Apixaban—Hepatobiliary disease—Brinzolamide—glaucoma	0.000943	0.00418	CcSEcCtD
Apixaban—Epistaxis—Brinzolamide—glaucoma	0.00094	0.00416	CcSEcCtD
Apixaban—Liver function test abnormal—Clonidine—glaucoma	0.000917	0.00406	CcSEcCtD
Apixaban—Haematuria—Pilocarpine—glaucoma	0.000914	0.00405	CcSEcCtD
Apixaban—Epistaxis—Pilocarpine—glaucoma	0.000904	0.004	CcSEcCtD
Apixaban—Breast disorder—Clonidine—glaucoma	0.000897	0.00397	CcSEcCtD
Apixaban—Hypersensitivity—Metipranolol—glaucoma	0.000896	0.00397	CcSEcCtD
Apixaban—Urinary tract disorder—Travoprost—glaucoma	0.000895	0.00396	CcSEcCtD
Apixaban—Eye disorder—Brimonidine—glaucoma	0.000891	0.00394	CcSEcCtD
Apixaban—Connective tissue disorder—Travoprost—glaucoma	0.000891	0.00394	CcSEcCtD
Apixaban—Urethral disorder—Travoprost—glaucoma	0.000889	0.00393	CcSEcCtD
Apixaban—Urinary tract disorder—Brinzolamide—glaucoma	0.000884	0.00391	CcSEcCtD
Apixaban—Gastrointestinal disorder—Methazolamide—glaucoma	0.00088	0.0039	CcSEcCtD
Apixaban—Connective tissue disorder—Brinzolamide—glaucoma	0.00088	0.00389	CcSEcCtD
Apixaban—Urethral disorder—Brinzolamide—glaucoma	0.000877	0.00389	CcSEcCtD
Apixaban—Syncope—Apraclonidine—glaucoma	0.000867	0.00384	CcSEcCtD
Apixaban—Angiopathy—Brimonidine—glaucoma	0.000865	0.00383	CcSEcCtD
Apixaban—Immune system disorder—Brimonidine—glaucoma	0.000861	0.00381	CcSEcCtD
Apixaban—Mediastinal disorder—Brimonidine—glaucoma	0.000859	0.0038	CcSEcCtD
Apixaban—Eye disorder—Travoprost—glaucoma	0.000847	0.00375	CcSEcCtD
Apixaban—Eye disorder—Brinzolamide—glaucoma	0.000837	0.0037	CcSEcCtD
Apixaban—Hypersensitivity—Carteolol—glaucoma	0.00083	0.00367	CcSEcCtD
Apixaban—Angiopathy—Travoprost—glaucoma	0.000823	0.00364	CcSEcCtD
Apixaban—Immune system disorder—Travoprost—glaucoma	0.000819	0.00363	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.000817	0.00362	CcSEcCtD
Apixaban—Mediastinal disorder—Travoprost—glaucoma	0.000817	0.00362	CcSEcCtD
Apixaban—Angiopathy—Brinzolamide—glaucoma	0.000812	0.0036	CcSEcCtD
Apixaban—Immune system disorder—Brinzolamide—glaucoma	0.000809	0.00358	CcSEcCtD
Apixaban—Mediastinal disorder—Brinzolamide—glaucoma	0.000807	0.00357	CcSEcCtD
Apixaban—Eye disorder—Pilocarpine—glaucoma	0.000804	0.00356	CcSEcCtD
Apixaban—Dizziness—Metipranolol—glaucoma	0.000804	0.00356	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.000792	0.00351	CcSEcCtD
Apixaban—Hypersensitivity—Levobunolol—glaucoma	0.000784	0.00347	CcSEcCtD
Apixaban—Breast disorder—Betaxolol—glaucoma	0.000781	0.00346	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Betaxolol—glaucoma	0.000779	0.00345	CcSEcCtD
Apixaban—Nervous system disorder—Apraclonidine—glaucoma	0.000774	0.00343	CcSEcCtD
Apixaban—Rash—Metipranolol—glaucoma	0.000767	0.00339	CcSEcCtD
Apixaban—Skin disorder—Apraclonidine—glaucoma	0.000766	0.00339	CcSEcCtD
Apixaban—Dermatitis—Metipranolol—glaucoma	0.000766	0.00339	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Betaxolol—glaucoma	0.000763	0.00338	CcSEcCtD
Apixaban—Nervous system disorder—Bimatoprost—glaucoma	0.00075	0.00332	CcSEcCtD
Apixaban—Dizziness—Carteolol—glaucoma	0.000745	0.0033	CcSEcCtD
Apixaban—Syncope—Brimonidine—glaucoma	0.000744	0.0033	CcSEcCtD
Apixaban—Skin disorder—Bimatoprost—glaucoma	0.000743	0.00329	CcSEcCtD
Apixaban—Dizziness—Diclofenamide—glaucoma	0.000732	0.00324	CcSEcCtD
Apixaban—Loss of consciousness—Brimonidine—glaucoma	0.000729	0.00323	CcSEcCtD
Apixaban—Nausea—Metipranolol—glaucoma	0.000722	0.0032	CcSEcCtD
Apixaban—Epistaxis—Clonidine—glaucoma	0.000722	0.0032	CcSEcCtD
Apixaban—Dizziness—Carbachol—glaucoma	0.000715	0.00316	CcSEcCtD
Apixaban—Syncope—Dorzolamide—glaucoma	0.000711	0.00315	CcSEcCtD
Apixaban—Anaphylactic shock—Acetazolamide—glaucoma	0.000706	0.00312	CcSEcCtD
Apixaban—Dizziness—Levobunolol—glaucoma	0.000704	0.00312	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.000702	0.00311	CcSEcCtD
Apixaban—Rash—Diclofenamide—glaucoma	0.000698	0.00309	CcSEcCtD
Apixaban—Loss of consciousness—Dorzolamide—glaucoma	0.000697	0.00308	CcSEcCtD
Apixaban—Shock—Acetazolamide—glaucoma	0.000694	0.00307	CcSEcCtD
Apixaban—Thrombocytopenia—Acetazolamide—glaucoma	0.000691	0.00306	CcSEcCtD
Apixaban—Rash—Carbachol—glaucoma	0.000681	0.00302	CcSEcCtD
Apixaban—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000681	0.00302	CcSEcCtD
Apixaban—Dermatitis—Carbachol—glaucoma	0.000681	0.00301	CcSEcCtD
Apixaban—Syncope—Pilocarpine—glaucoma	0.000672	0.00297	CcSEcCtD
Apixaban—Nausea—Carteolol—glaucoma	0.000669	0.00296	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000667	0.00295	CcSEcCtD
Apixaban—Shock—Brimonidine—glaucoma	0.000666	0.00295	CcSEcCtD
Apixaban—Nervous system disorder—Brimonidine—glaucoma	0.000664	0.00294	CcSEcCtD
Apixaban—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00066	0.00292	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000659	0.00292	CcSEcCtD
Apixaban—Loss of consciousness—Pilocarpine—glaucoma	0.000658	0.00291	CcSEcCtD
Apixaban—Skin disorder—Brimonidine—glaucoma	0.000658	0.00291	CcSEcCtD
Apixaban—Nausea—Diclofenamide—glaucoma	0.000658	0.00291	CcSEcCtD
Apixaban—Dizziness—Latanoprost—glaucoma	0.000653	0.00289	CcSEcCtD
Apixaban—Liver function test abnormal—Timolol—glaucoma	0.000652	0.00289	CcSEcCtD
Apixaban—Anaphylactic shock—Dorzolamide—glaucoma	0.000647	0.00286	CcSEcCtD
Apixaban—Rash—Methazolamide—glaucoma	0.000643	0.00285	CcSEcCtD
Apixaban—Dermatitis—Methazolamide—glaucoma	0.000642	0.00284	CcSEcCtD
Apixaban—Eye disorder—Clonidine—glaucoma	0.000642	0.00284	CcSEcCtD
Apixaban—Nausea—Carbachol—glaucoma	0.000642	0.00284	CcSEcCtD
Apixaban—Breast disorder—Timolol—glaucoma	0.000638	0.00283	CcSEcCtD
Apixaban—Shock—Dorzolamide—glaucoma	0.000636	0.00282	CcSEcCtD
Apixaban—Hypotension—Brimonidine—glaucoma	0.000633	0.0028	CcSEcCtD
Apixaban—Nausea—Levobunolol—glaucoma	0.000632	0.0028	CcSEcCtD
Apixaban—Nervous system disorder—Travoprost—glaucoma	0.000632	0.0028	CcSEcCtD
Apixaban—Epistaxis—Betaxolol—glaucoma	0.000628	0.00278	CcSEcCtD
Apixaban—Skin disorder—Travoprost—glaucoma	0.000626	0.00277	CcSEcCtD
Apixaban—Nervous system disorder—Brinzolamide—glaucoma	0.000624	0.00276	CcSEcCtD
Apixaban—Angiopathy—Clonidine—glaucoma	0.000623	0.00276	CcSEcCtD
Apixaban—Rash—Latanoprost—glaucoma	0.000622	0.00276	CcSEcCtD
Apixaban—Dermatitis—Latanoprost—glaucoma	0.000622	0.00275	CcSEcCtD
Apixaban—Mediastinal disorder—Clonidine—glaucoma	0.000619	0.00274	CcSEcCtD
Apixaban—Skin disorder—Brinzolamide—glaucoma	0.000618	0.00274	CcSEcCtD
Apixaban—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000609	0.0027	CcSEcCtD
Apixaban—Nausea—Methazolamide—glaucoma	0.000606	0.00268	CcSEcCtD
Apixaban—Hypotension—Dorzolamide—glaucoma	0.000604	0.00268	CcSEcCtD
Apixaban—Hypotension—Travoprost—glaucoma	0.000602	0.00266	CcSEcCtD
Apixaban—Shock—Pilocarpine—glaucoma	0.000601	0.00266	CcSEcCtD
Apixaban—Thrombocytopenia—Pilocarpine—glaucoma	0.000598	0.00265	CcSEcCtD
Apixaban—Hypotension—Brinzolamide—glaucoma	0.000594	0.00263	CcSEcCtD
Apixaban—Gastrointestinal disorder—Brimonidine—glaucoma	0.000585	0.00259	CcSEcCtD
Apixaban—Hypersensitivity—Apraclonidine—glaucoma	0.000581	0.00257	CcSEcCtD
Apixaban—Hypotension—Pilocarpine—glaucoma	0.000571	0.00253	CcSEcCtD
Apixaban—Eye disorder—Betaxolol—glaucoma	0.000559	0.00248	CcSEcCtD
Apixaban—Gastrointestinal disorder—Travoprost—glaucoma	0.000556	0.00246	CcSEcCtD
Apixaban—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000549	0.00243	CcSEcCtD
Apixaban—Angiopathy—Betaxolol—glaucoma	0.000543	0.0024	CcSEcCtD
Apixaban—Immune system disorder—Betaxolol—glaucoma	0.00054	0.00239	CcSEcCtD
Apixaban—Mediastinal disorder—Betaxolol—glaucoma	0.000539	0.00239	CcSEcCtD
Apixaban—Syncope—Clonidine—glaucoma	0.000536	0.00237	CcSEcCtD
Apixaban—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000528	0.00234	CcSEcCtD
Apixaban—Loss of consciousness—Clonidine—glaucoma	0.000526	0.00233	CcSEcCtD
Apixaban—Dizziness—Apraclonidine—glaucoma	0.000522	0.00231	CcSEcCtD
Apixaban—Epistaxis—Timolol—glaucoma	0.000513	0.00227	CcSEcCtD
Apixaban—Dizziness—Bimatoprost—glaucoma	0.000506	0.00224	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000506	0.00224	CcSEcCtD
Apixaban—Hypersensitivity—Brimonidine—glaucoma	0.000499	0.00221	CcSEcCtD
Apixaban—Dermatitis—Apraclonidine—glaucoma	0.000497	0.0022	CcSEcCtD
Apixaban—Rash—Bimatoprost—glaucoma	0.000482	0.00214	CcSEcCtD
Apixaban—Dermatitis—Bimatoprost—glaucoma	0.000482	0.00213	CcSEcCtD
Apixaban—Anaemia—Betaxolol—glaucoma	0.000481	0.00213	CcSEcCtD
Apixaban—Shock—Clonidine—glaucoma	0.00048	0.00213	CcSEcCtD
Apixaban—Connective tissue disorder—Timolol—glaucoma	0.00048	0.00213	CcSEcCtD
Apixaban—Nervous system disorder—Clonidine—glaucoma	0.000479	0.00212	CcSEcCtD
Apixaban—Thrombocytopenia—Clonidine—glaucoma	0.000478	0.00212	CcSEcCtD
Apixaban—Hypersensitivity—Dorzolamide—glaucoma	0.000477	0.00211	CcSEcCtD
Apixaban—Hypersensitivity—Travoprost—glaucoma	0.000475	0.0021	CcSEcCtD
Apixaban—Skin disorder—Clonidine—glaucoma	0.000474	0.0021	CcSEcCtD
Apixaban—Nausea—Apraclonidine—glaucoma	0.000469	0.00207	CcSEcCtD
Apixaban—Hypersensitivity—Brinzolamide—glaucoma	0.000469	0.00207	CcSEcCtD
Apixaban—Syncope—Betaxolol—glaucoma	0.000467	0.00207	CcSEcCtD
Apixaban—Dizziness—Acetazolamide—glaucoma	0.000467	0.00207	CcSEcCtD
Apixaban—Loss of consciousness—Betaxolol—glaucoma	0.000458	0.00203	CcSEcCtD
Apixaban—Eye disorder—Timolol—glaucoma	0.000457	0.00202	CcSEcCtD
Apixaban—Hypotension—Clonidine—glaucoma	0.000456	0.00202	CcSEcCtD
Apixaban—Nausea—Bimatoprost—glaucoma	0.000454	0.00201	CcSEcCtD
Apixaban—Hypersensitivity—Pilocarpine—glaucoma	0.00045	0.00199	CcSEcCtD
Apixaban—Dizziness—Brimonidine—glaucoma	0.000448	0.00198	CcSEcCtD
Apixaban—Angiopathy—Timolol—glaucoma	0.000443	0.00196	CcSEcCtD
Apixaban—Immune system disorder—Timolol—glaucoma	0.000441	0.00195	CcSEcCtD
Apixaban—Mediastinal disorder—Timolol—glaucoma	0.00044	0.00195	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.00044	0.00195	CcSEcCtD
Apixaban—Dizziness—Dorzolamide—glaucoma	0.000428	0.00189	CcSEcCtD
Apixaban—Rash—Brimonidine—glaucoma	0.000427	0.00189	CcSEcCtD
Apixaban—Dermatitis—Brimonidine—glaucoma	0.000427	0.00189	CcSEcCtD
Apixaban—Dizziness—Travoprost—glaucoma	0.000426	0.00189	CcSEcCtD
Apixaban—Gastrointestinal disorder—Clonidine—glaucoma	0.000421	0.00187	CcSEcCtD
Apixaban—Dizziness—Brinzolamide—glaucoma	0.000421	0.00186	CcSEcCtD
Apixaban—Nausea—Acetazolamide—glaucoma	0.000419	0.00186	CcSEcCtD
Apixaban—Shock—Betaxolol—glaucoma	0.000418	0.00185	CcSEcCtD
Apixaban—Nervous system disorder—Betaxolol—glaucoma	0.000417	0.00185	CcSEcCtD
Apixaban—Thrombocytopenia—Betaxolol—glaucoma	0.000416	0.00184	CcSEcCtD
Apixaban—Skin disorder—Betaxolol—glaucoma	0.000413	0.00183	CcSEcCtD
Apixaban—Rash—Dorzolamide—glaucoma	0.000408	0.00181	CcSEcCtD
Apixaban—Dermatitis—Dorzolamide—glaucoma	0.000407	0.0018	CcSEcCtD
Apixaban—Rash—Travoprost—glaucoma	0.000406	0.0018	CcSEcCtD
Apixaban—Dermatitis—Travoprost—glaucoma	0.000406	0.0018	CcSEcCtD
Apixaban—Dizziness—Pilocarpine—glaucoma	0.000404	0.00179	CcSEcCtD
Apixaban—Nausea—Brimonidine—glaucoma	0.000402	0.00178	CcSEcCtD
Apixaban—Rash—Brinzolamide—glaucoma	0.000401	0.00178	CcSEcCtD
Apixaban—Dermatitis—Brinzolamide—glaucoma	0.000401	0.00177	CcSEcCtD
Apixaban—Hypotension—Betaxolol—glaucoma	0.000397	0.00176	CcSEcCtD
Apixaban—Rash—Pilocarpine—glaucoma	0.000385	0.00171	CcSEcCtD
Apixaban—Dermatitis—Pilocarpine—glaucoma	0.000385	0.0017	CcSEcCtD
Apixaban—Nausea—Dorzolamide—glaucoma	0.000384	0.0017	CcSEcCtD
Apixaban—Nausea—Travoprost—glaucoma	0.000383	0.00169	CcSEcCtD
Apixaban—Syncope—Timolol—glaucoma	0.000381	0.00169	CcSEcCtD
Apixaban—Nausea—Brinzolamide—glaucoma	0.000378	0.00167	CcSEcCtD
Apixaban—Loss of consciousness—Timolol—glaucoma	0.000374	0.00166	CcSEcCtD
Apixaban—Gastrointestinal disorder—Betaxolol—glaucoma	0.000367	0.00162	CcSEcCtD
Apixaban—Nausea—Pilocarpine—glaucoma	0.000363	0.00161	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.00036	0.00159	CcSEcCtD
Apixaban—Hypersensitivity—Clonidine—glaucoma	0.00036	0.00159	CcSEcCtD
Apixaban—Anaphylactic shock—Timolol—glaucoma	0.000347	0.00154	CcSEcCtD
Apixaban—Shock—Timolol—glaucoma	0.000342	0.00151	CcSEcCtD
Apixaban—Nervous system disorder—Timolol—glaucoma	0.00034	0.00151	CcSEcCtD
Apixaban—Skin disorder—Timolol—glaucoma	0.000337	0.00149	CcSEcCtD
Apixaban—Hypotension—Timolol—glaucoma	0.000324	0.00144	CcSEcCtD
Apixaban—Dizziness—Clonidine—glaucoma	0.000323	0.00143	CcSEcCtD
Apixaban—Hypersensitivity—Betaxolol—glaucoma	0.000313	0.00139	CcSEcCtD
Apixaban—Rash—Clonidine—glaucoma	0.000308	0.00136	CcSEcCtD
Apixaban—Dermatitis—Clonidine—glaucoma	0.000307	0.00136	CcSEcCtD
Apixaban—Gastrointestinal disorder—Timolol—glaucoma	0.0003	0.00133	CcSEcCtD
Apixaban—Nausea—Clonidine—glaucoma	0.00029	0.00128	CcSEcCtD
Apixaban—Dizziness—Betaxolol—glaucoma	0.000281	0.00124	CcSEcCtD
Apixaban—Rash—Betaxolol—glaucoma	0.000268	0.00119	CcSEcCtD
Apixaban—Dermatitis—Betaxolol—glaucoma	0.000268	0.00119	CcSEcCtD
Apixaban—Hypersensitivity—Timolol—glaucoma	0.000256	0.00113	CcSEcCtD
Apixaban—Nausea—Betaxolol—glaucoma	0.000252	0.00112	CcSEcCtD
Apixaban—Dizziness—Timolol—glaucoma	0.00023	0.00102	CcSEcCtD
Apixaban—Rash—Timolol—glaucoma	0.000219	0.000969	CcSEcCtD
Apixaban—Dermatitis—Timolol—glaucoma	0.000219	0.000968	CcSEcCtD
Apixaban—Nausea—Timolol—glaucoma	0.000206	0.000913	CcSEcCtD
Apixaban—CYP2J2—Metabolism—CA1—glaucoma	0.000174	0.00264	CbGpPWpGaD
Apixaban—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000169	0.00257	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—CTSA—glaucoma	0.000168	0.00255	CbGpPWpGaD
Apixaban—ABCG2—Fluoropyrimidine Activity—TP53—glaucoma	0.000163	0.00248	CbGpPWpGaD
Apixaban—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000163	0.00247	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—PAX6—glaucoma	0.000163	0.00247	CbGpPWpGaD
Apixaban—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000161	0.00244	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—CA2—glaucoma	0.000159	0.00241	CbGpPWpGaD
Apixaban—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000155	0.00236	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000155	0.00236	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000155	0.00236	CbGpPWpGaD
Apixaban—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000155	0.00235	CbGpPWpGaD
Apixaban—F10—Hemostasis—SOD1—glaucoma	0.000154	0.00234	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000153	0.00232	CbGpPWpGaD
Apixaban—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.00015	0.00229	CbGpPWpGaD
Apixaban—CYP3A5—Biological oxidations—GSTT1—glaucoma	0.000146	0.00222	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CA5A—glaucoma	0.000143	0.00217	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—NARFL—glaucoma	0.000143	0.00217	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.00014	0.00213	CbGpPWpGaD
Apixaban—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000132	0.00201	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—IL1A—glaucoma	0.000132	0.002	CbGpPWpGaD
Apixaban—CYP2C8—Biological oxidations—GSTT1—glaucoma	0.000127	0.00192	CbGpPWpGaD
Apixaban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000126	0.00191	CbGpPWpGaD
Apixaban—ABCG2—HIF-1-alpha transcription factor network—VEGFA—glaucoma	0.000124	0.00189	CbGpPWpGaD
Apixaban—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000124	0.00188	CbGpPWpGaD
Apixaban—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	0.000122	0.00186	CbGpPWpGaD
Apixaban—F10—Hemostasis—MMP1—glaucoma	0.000118	0.00179	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—FAS—glaucoma	0.000117	0.00178	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000117	0.00178	CbGpPWpGaD
Apixaban—CYP3A5—Biological oxidations—CYP1B1—glaucoma	0.000116	0.00177	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—C3—glaucoma	0.000116	0.00176	CbGpPWpGaD
Apixaban—CYP3A5—Metapathway biotransformation—CYP1B1—glaucoma	0.000115	0.00174	CbGpPWpGaD
Apixaban—CYP2C19—Biological oxidations—GSTT1—glaucoma	0.000113	0.00172	CbGpPWpGaD
Apixaban—F10—Hemostasis—CAV1—glaucoma	0.000113	0.00171	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—TXN—glaucoma	0.000112	0.0017	CbGpPWpGaD
Apixaban—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	0.000109	0.00166	CbGpPWpGaD
Apixaban—F10—Hemostasis—FN1—glaucoma	0.000107	0.00163	CbGpPWpGaD
Apixaban—CYP2C9—Biological oxidations—GSTT1—glaucoma	0.000103	0.00157	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CA5A—glaucoma	0.000102	0.00156	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—NARFL—glaucoma	0.000102	0.00156	CbGpPWpGaD
Apixaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000102	0.00156	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000102	0.00155	CbGpPWpGaD
Apixaban—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000102	0.00155	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000101	0.00154	CbGpPWpGaD
Apixaban—CYP2C8—Biological oxidations—CYP1B1—glaucoma	0.000101	0.00153	CbGpPWpGaD
Apixaban—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	9.95e-05	0.00151	CbGpPWpGaD
Apixaban—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	9.94e-05	0.00151	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	9.91e-05	0.00151	CbGpPWpGaD
Apixaban—CYP1A2—Phase II conjugation—GSTM1—glaucoma	9.58e-05	0.00146	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	9.48e-05	0.00144	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	9.42e-05	0.00143	CbGpPWpGaD
Apixaban—CYP3A5—Biological oxidations—GSTM1—glaucoma	9.31e-05	0.00141	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—MMP1—glaucoma	9.26e-05	0.00141	CbGpPWpGaD
Apixaban—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	9.18e-05	0.00139	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	9.08e-05	0.00138	CbGpPWpGaD
Apixaban—CYP2C19—Biological oxidations—CYP1B1—glaucoma	9e-05	0.00137	CbGpPWpGaD
Apixaban—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	8.88e-05	0.00135	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CA5A—glaucoma	8.87e-05	0.00135	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—NARFL—glaucoma	8.87e-05	0.00135	CbGpPWpGaD
Apixaban—CYP1A2—Biological oxidations—GSTT1—glaucoma	8.8e-05	0.00134	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—GSTT1—glaucoma	8.67e-05	0.00132	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	8.6e-05	0.00131	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	8.6e-05	0.00131	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.56e-05	0.0013	CbGpPWpGaD
Apixaban—F10—Hemostasis—NOS3—glaucoma	8.53e-05	0.0013	CbGpPWpGaD
Apixaban—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	8.49e-05	0.00129	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	8.41e-05	0.00128	CbGpPWpGaD
Apixaban—CYP2C9—Biological oxidations—CYP1B1—glaucoma	8.21e-05	0.00125	CbGpPWpGaD
Apixaban—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	8.1e-05	0.00123	CbGpPWpGaD
Apixaban—CYP2C8—Biological oxidations—GSTM1—glaucoma	8.06e-05	0.00123	CbGpPWpGaD
Apixaban—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	7.95e-05	0.00121	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NARFL—glaucoma	7.92e-05	0.0012	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CA5A—glaucoma	7.92e-05	0.0012	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NARFL—glaucoma	7.73e-05	0.00117	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CA5A—glaucoma	7.73e-05	0.00117	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	7.67e-05	0.00117	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	7.39e-05	0.00112	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NARFL—glaucoma	7.22e-05	0.0011	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CA5A—glaucoma	7.22e-05	0.0011	CbGpPWpGaD
Apixaban—CYP2C19—Biological oxidations—GSTM1—glaucoma	7.2e-05	0.00109	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—MMP2—glaucoma	7.16e-05	0.00109	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	7.15e-05	0.00109	CbGpPWpGaD
Apixaban—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	7.1e-05	0.00108	CbGpPWpGaD
Apixaban—CYP1A2—Biological oxidations—CYP1B1—glaucoma	7.01e-05	0.00107	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.99e-05	0.00106	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CA1—glaucoma	6.98e-05	0.00106	CbGpPWpGaD
Apixaban—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	6.92e-05	0.00105	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—CYP1B1—glaucoma	6.91e-05	0.00105	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—ABCA1—glaucoma	6.91e-05	0.00105	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	6.81e-05	0.00103	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—GSTT1—glaucoma	6.79e-05	0.00103	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	6.77e-05	0.00103	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CTSA—glaucoma	6.76e-05	0.00103	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	6.71e-05	0.00102	CbGpPWpGaD
Apixaban—CYP2C9—Biological oxidations—GSTM1—glaucoma	6.56e-05	0.000997	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.55e-05	0.000996	CbGpPWpGaD
Apixaban—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	6.47e-05	0.000983	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CA2—glaucoma	6.38e-05	0.00097	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.32e-05	0.000961	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CA5A—glaucoma	6.17e-05	0.000937	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NARFL—glaucoma	6.17e-05	0.000937	CbGpPWpGaD
Apixaban—F10—Hemostasis—VEGFA—glaucoma	6.14e-05	0.000934	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	6.13e-05	0.000931	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	6.13e-05	0.000931	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—VEGFA—glaucoma	5.81e-05	0.000883	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	5.79e-05	0.00088	CbGpPWpGaD
Apixaban—CYP1A2—Biological oxidations—GSTM1—glaucoma	5.61e-05	0.000852	CbGpPWpGaD
Apixaban—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	5.53e-05	0.00084	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—GSTM1—glaucoma	5.52e-05	0.000839	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—CYP1B1—glaucoma	5.41e-05	0.000823	CbGpPWpGaD
Apixaban—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	5.34e-05	0.000811	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CA1—glaucoma	5e-05	0.00076	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—TNF—glaucoma	4.98e-05	0.000757	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	4.95e-05	0.000752	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—MTHFR—glaucoma	4.88e-05	0.000742	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CTSA—glaucoma	4.84e-05	0.000736	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NARFL—glaucoma	4.76e-05	0.000724	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CA5A—glaucoma	4.76e-05	0.000724	CbGpPWpGaD
Apixaban—F10—Hemostasis—TP53—glaucoma	4.64e-05	0.000706	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.63e-05	0.000703	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CA2—glaucoma	4.57e-05	0.000695	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—APOE—glaucoma	4.54e-05	0.00069	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—CAV1—glaucoma	4.5e-05	0.000684	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—TXN—glaucoma	4.5e-05	0.000684	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CA1—glaucoma	4.33e-05	0.000658	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—GSTM1—glaucoma	4.33e-05	0.000658	CbGpPWpGaD
Apixaban—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	4.27e-05	0.000649	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CTSA—glaucoma	4.2e-05	0.000638	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CA2—glaucoma	3.96e-05	0.000602	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.87e-05	0.000588	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.87e-05	0.000588	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CA1—glaucoma	3.87e-05	0.000588	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CA1—glaucoma	3.77e-05	0.000573	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CTSA—glaucoma	3.75e-05	0.000569	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CTSA—glaucoma	3.66e-05	0.000555	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	3.64e-05	0.000553	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CA2—glaucoma	3.54e-05	0.000537	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CA1—glaucoma	3.53e-05	0.000536	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GSTT1—glaucoma	3.49e-05	0.00053	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.46e-05	0.000525	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.46e-05	0.000525	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CA2—glaucoma	3.45e-05	0.000525	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	3.45e-05	0.000524	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CTSA—glaucoma	3.41e-05	0.000519	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—NOS3—glaucoma	3.4e-05	0.000517	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CA2—glaucoma	3.22e-05	0.00049	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—TXN—glaucoma	3.22e-05	0.00049	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.15e-05	0.000479	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.15e-05	0.000479	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PTGS2—glaucoma	3.11e-05	0.000473	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CA1—glaucoma	3.01e-05	0.000458	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CTSA—glaucoma	2.92e-05	0.000443	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	2.87e-05	0.000436	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—TXN—glaucoma	2.79e-05	0.000424	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ABCA1—glaucoma	2.78e-05	0.000422	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CYP1B1—glaucoma	2.78e-05	0.000422	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CA2—glaucoma	2.76e-05	0.000419	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.69e-05	0.000409	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.69e-05	0.000409	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.55e-05	0.000387	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.52e-05	0.000383	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTT1—glaucoma	2.5e-05	0.00038	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—TXN—glaucoma	2.49e-05	0.000379	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.46e-05	0.000374	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—TXN—glaucoma	2.43e-05	0.00037	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CA1—glaucoma	2.33e-05	0.000353	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.27e-05	0.000345	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—TXN—glaucoma	2.27e-05	0.000345	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.25e-05	0.000342	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CTSA—glaucoma	2.25e-05	0.000342	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GSTM1—glaucoma	2.22e-05	0.000338	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.17e-05	0.000329	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTT1—glaucoma	2.16e-05	0.000329	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CA2—glaucoma	2.13e-05	0.000323	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.07e-05	0.000315	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.05e-05	0.000312	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP1B1—glaucoma	1.99e-05	0.000303	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ABCA1—glaucoma	1.99e-05	0.000303	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—MTHFR—glaucoma	1.96e-05	0.000298	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—TXN—glaucoma	1.94e-05	0.000295	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTT1—glaucoma	1.93e-05	0.000294	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTT1—glaucoma	1.89e-05	0.000287	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—APOE—glaucoma	1.83e-05	0.000278	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CAV1—glaucoma	1.81e-05	0.000275	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.77e-05	0.000269	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTT1—glaucoma	1.76e-05	0.000268	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.76e-05	0.000267	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.75e-05	0.000265	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ABCA1—glaucoma	1.72e-05	0.000262	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP1B1—glaucoma	1.72e-05	0.000262	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTM1—glaucoma	1.59e-05	0.000242	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.56e-05	0.000237	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP1B1—glaucoma	1.54e-05	0.000234	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ABCA1—glaucoma	1.54e-05	0.000234	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTT1—glaucoma	1.51e-05	0.000229	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ABCA1—glaucoma	1.5e-05	0.000228	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP1B1—glaucoma	1.5e-05	0.000228	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—TXN—glaucoma	1.5e-05	0.000228	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.42e-05	0.000216	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—MTHFR—glaucoma	1.41e-05	0.000214	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ABCA1—glaucoma	1.4e-05	0.000213	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP1B1—glaucoma	1.4e-05	0.000213	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTM1—glaucoma	1.38e-05	0.00021	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—NOS3—glaucoma	1.37e-05	0.000208	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—APOE—glaucoma	1.31e-05	0.000199	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CAV1—glaucoma	1.3e-05	0.000197	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTGS2—glaucoma	1.25e-05	0.00019	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTM1—glaucoma	1.23e-05	0.000187	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—MTHFR—glaucoma	1.22e-05	0.000185	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.21e-05	0.000184	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTM1—glaucoma	1.2e-05	0.000183	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP1B1—glaucoma	1.2e-05	0.000182	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ABCA1—glaucoma	1.2e-05	0.000182	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTT1—glaucoma	1.16e-05	0.000177	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—APOE—glaucoma	1.13e-05	0.000172	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CAV1—glaucoma	1.12e-05	0.000171	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTM1—glaucoma	1.12e-05	0.000171	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—MTHFR—glaucoma	1.09e-05	0.000165	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—MTHFR—glaucoma	1.06e-05	0.000161	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—APOE—glaucoma	1.01e-05	0.000154	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CAV1—glaucoma	1e-05	0.000152	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—MTHFR—glaucoma	9.92e-06	0.000151	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—APOE—glaucoma	9.88e-06	0.00015	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—NOS3—glaucoma	9.81e-06	0.000149	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CAV1—glaucoma	9.79e-06	0.000149	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTM1—glaucoma	9.59e-06	0.000146	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ABCA1—glaucoma	9.26e-06	0.000141	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP1B1—glaucoma	9.26e-06	0.000141	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—APOE—glaucoma	9.23e-06	0.00014	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CAV1—glaucoma	9.15e-06	0.000139	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTGS2—glaucoma	8.97e-06	0.000136	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—NOS3—glaucoma	8.5e-06	0.000129	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—MTHFR—glaucoma	8.47e-06	0.000129	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—APOE—glaucoma	7.89e-06	0.00012	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CAV1—glaucoma	7.82e-06	0.000119	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTGS2—glaucoma	7.77e-06	0.000118	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NOS3—glaucoma	7.59e-06	0.000115	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NOS3—glaucoma	7.4e-06	0.000113	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTM1—glaucoma	7.4e-06	0.000112	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTGS2—glaucoma	6.94e-06	0.000105	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NOS3—glaucoma	6.92e-06	0.000105	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTGS2—glaucoma	6.77e-06	0.000103	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—MTHFR—glaucoma	6.54e-06	9.94e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTGS2—glaucoma	6.33e-06	9.61e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOE—glaucoma	6.09e-06	9.25e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CAV1—glaucoma	6.03e-06	9.17e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NOS3—glaucoma	5.91e-06	8.98e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTGS2—glaucoma	5.41e-06	8.21e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NOS3—glaucoma	4.56e-06	6.93e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTGS2—glaucoma	4.17e-06	6.34e-05	CbGpPWpGaD
